Adam Frederik Sander Bertelsen

Adam Frederik Sander Bertelsen

Professor


  1. 2022
  2. Published

    Freeze-Drying of a Capsid Virus-like Particle-Based Platform Allows Stable Storage of Vaccines at Ambient Temperature

    Aves, Kara-Lee, Janitzek, C. M., Fougeroux, Cyrielle Elyette, Theander, Thor Grundtvig & Sander, Adam F. , 2022, In: Pharmaceutics. 14, 6, 1301.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Preclinical Efficacy of a Capsid Virus-like Particle-Based Vaccine Targeting IL-1β for Treatment of Allergic Contact Dermatitis

    Goksøyr, L., Funch, Anders Boutrup, Okholm, A. K., Theander, Thor Grundtvig, de Jongh, W. A., Bonefeld, Charlotte Menne & Sander, Adam F. , 2022, In: Vaccines. 10, 5, 828.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    The C-terminal tail of α-synuclein protects against aggregate replication but is critical for oligomerization

    Farzadfard, A., Pedersen, J. N., Meisl, G., Somavarapu, A. K., Alam, P., Goksøyr, L., Nielsen, Morten Agertoug, Sander, Adam F. , Knowles, T. P. J., Pedersen, J. S. & Otzen, D. E., 2022, In: Communications Biology . 5, 1, 123.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Two-component vaccine consisting of virus-like particles displaying hepatitis C virus envelope protein 2 oligomers

    Prentø, Jannick, Janitzek, C. M., Velázquez-Moctezuma, R., Sørensen, Andreas Holst Holmegaard, Jørgensen, T., Clemmensen, S., Soroka, V., Thrane, Susan, Theander, Thor Grundtvig, Nielsen, Morten Agertoug, Salanti, Ali, Bukh, Jens & Sander, Adam F. , 2022, In: npj Vaccines. 7, 148.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Virus-like particles displaying recombinant Der p 1 allergen to optimize IgG blocking antibody response

    Jitthamstaporn, S., Sander, Adam F. & Jacquet, A., 2022, In: Allergy: European Journal of Allergy and Clinical Immunology. 77, 2, p. 664-667

    Research output: Contribution to journalLetterResearchpeer-review

  7. 2023
  8. Published

    Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA

    Doritchamou, J., Nielsen, M. A., Chêne, A., Viebig, N. K., Lambert, L. E., Sander, A. F., Semblat, J. P., Hundt, S., Orr-Gonzalez, S., Janitzek, C. M., Spiegel, A. J., Clemmensen, S. B., Thomas, M. L., Nason, M. C., Snow-Smith, M., Barnafo, E. K., Shiloach, J., Chen, B. B., Nadakal, S., Highsmith, K. & 15 others, Ouahes, T., Conteh, S., Sharma, A., Torano, H., Butler, B., Reiter, K., Rausch, K. M., Scaria, P. V., Anderson, C., Narum, D. L., Salanti, Ali, Fried, M., Theander, Thor Grundtvig, Gamain, B. & Duffy, P. E., 2023, In: Lab Animal. 52, 12, p. 315-323

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    A Virus-like Particle-Based F4 Enterotoxigenic Escherichia coli Vaccine Is Inhibited by Maternally Derived Antibodies in Piglets but Generates Robust Responses in Sows

    Aves, Kara-Lee, Guerra, Priscila Regina, Fresno, A. H., Saraiva, M. M. S., Cox, E., Bækbo, P. J., Nielsen, Morten Agertoug, Sander, Adam F. & Olsen, John Elmerdahl, 2023, In: Pathogens. 12, 12, 19 p., 1388.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    A cVLP-based vaccine displaying full-length PCSK9 elicits a higher reduction in plasma PCSK9 than similar peptide-based cVLP vaccines

    Goksøyr, L., Skrzypczak, M., Sampson, M., Nielsen, Morten Agertoug, Salanti, Ali, Theander, Thor Grundtvig, Remaley, A. T., Jongh, W. A. D. & Sander, Adam F. , 2023, In: Vaccines. 11, 1, 2.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines

    Van Coillie, J., Pongracz, T., Šuštić, T., Wang, W., Nouta, J., Le Gars, M., Keijzer, S., Linty, F., Cristianawati, O., Keijser, J. B. D., Visser, R., van Vught, L. A., Slim, M. A., van Mourik, N., Smit, M. J., Sander, A., Schmidt, D. E., Steenhuis, M., Rispens, T., Nielsen, M. A. & 31 others, Mordmüller, B. G., Vlaar, A. P. J., Ellen van der Schoot, C., Roozendaal, R., Wuhrer, M., Vidarsson, G., Appelman, B., van de Beek, D., Bomers, M. K., de Brabander, J., Brouwer, M. C., Buis, D. T. P., Chekrouni, N., van Gils, M. J., de Jong, M. D., Lavell, A. H. A., Olie, S. E., Peters, E. J. G., Reijnders, T. D. Y., Schinkel, M., Schuurman, A. R., Sikkens, J. J., Smulders, Y. M., Wiersinga, J. W., Spinello, A., Bassoli, C., Bestetti, G., Corbellino, M., Salanti, Ali, Theander, Thor Grundtvig & in collaboration with the UMC COVID-19 S3/HCW study group, I. C. W. T. U. C. S. S. G., 2023, In: iScience. 26, 9, p. 1-15 107619.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Development of a Tag/Catcher-mediated capsid virus-like particle vaccine presenting the conserved Neisseria gonorrhoeae SliC antigen that blocks human lysozyme

    Martinez, Fabian Guadalupe, Zielke, R. A., Fougeroux, Cyrielle Elyette, Li, L., Sander, Adam F. & Sikora, A. E., 2023, In: Infection and Immunity. 91, 12, 21 p., e00245-23.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 365538742